Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
Emefcy
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Developer of a simple, scalable, decentralized wastewater treatment solution with 90% less power consumption and Electrogenic Bioreactor (EBR) that treats industrial wastewater and generates green electricity

Founded in 2007
Founded in

Company type Public Public (SAV)
Company type

Industry Group waste & recycling

Sector wastewater

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Israel Caesarea, Israel
Address
City
State
Zip
Country

Parent Companies Fluence Water

Website

Updated by Eytan Levy at Emefcy on 01/12/2015

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
Partnerships
Save
Add Partnership
Date Partner Type
03/31/2017
RWL Water Group RWL Water Group
Strategic alliance to accelerate the respective company's penetration in the Chinese water treatment market.
View source    
Confirmed by RWL Water Group
Channel Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

12/24/2015

IPO status

Listed

IPO Type

IPO

Amount

$25M

Initial shares

Ticker symbol

SAV

Exchange listed

ASX

Prospectus URL

Prospectus

Source URL

Source

Description

Caesarea-based Emefcy, which develops technological solutions for sewage treatment, was merged last week into Savcor, an Australian stock exchange shell, accompanied by a financing round

Cancel Save
Add Investment
Date Investors Type Amount
12/19/2012 Plan B Ventures Plan B Ventures , Pond Venture Partners Pond Venture Partners , True North Venture Partners True North Venture Partners , GE Ventures GE Ventures , Israel Cleantech Ventures Israel Cleantech Ventures (5)
Post-money valuation of
Emefcy closes its third funding round led by True North Venture Partners with participation by existing investors.
 Series B $6,000,000
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics

Emefcy SABRE

SABRE stands for Spiral Aerobic Biofilm Reactor. It is a simple, low cost, modular and scalable solution for small and medium size wastewater treatment plants. SABRE is based on self-respiring membranes which provide oxygen for the biological treatment process. By eliminating the need to blow compressed air through the wastewater for aeration, SABRE saves up to 90% of the power. The modular product design enables distributed treatment and gradual expansion possibilities over time. SABRE is ideal for wastewater treatment and reuse in small municipalities, hotels, resorts, casinos, campgrounds, mining camps, commercial centers, golf courses, and many others.

 Pilot/Early Revenue Products - Wholesale
$/kW (current)
$/kW (projected)
$/kWh (current)
$/kWh (projected)
Delete
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font